Status:

COMPLETED

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborating Sponsors:

University of Texas

Conditions:

Cocaine-Related Disorders

Substance-Related Disorders

Eligibility:

All Genders

18-45 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.

Eligibility Criteria

Please contact site for information.

Key Trial Info

Start Date :

August 1 1997

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2001

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00000304

Start Date

August 1 1997

End Date

August 1 2001

Last Update

January 12 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Health Science Center

Houston, Texas, United States, 77225

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 | DecenTrialz